Latest news
AbbVie trims 2026 profit view on Apogee deal, tops second-quarter estimates - KELO-AMKELO-AM · Fri, 31 Jul 2026 15:31:52 GMTAbbVie Earnings Beat Forecasts as Skyrizi Sales Soar 24%. Why the Stock Is Falling. - Barron'sBarron's · Fri, 31 Jul 2026 07:00:00 GMTAbbVie's Skyrizi shrugs off new competition as it thrives in growing psoriasis market - Fierce PharmaFierce Pharma · Fri, 31 Jul 2026 07:00:00 GMT